Most Recent
AstraZeneca has denied claims by Pharmacor that a patent for its diabetes drug Forxiga is invalid and that an extension of the patent's term was wrongly granted.
Adelaide-based Mayne Pharma Group has settled its dispute with generic drug maker Teva Pharmaceuticals over patents covering hormone replacement drug IMVEXXY.
Communication minister Anika Wells has said the government is considering adding an individual right to sue under legislation tabled this week that introduces a digital duty of care.
The consumer watchdog has launched proceedings against Kmart for allegedly breaching the Australian Consumer Law by selling cosmetic nail glue without warnings and products with non-compliant button batteries.
An appeals court has found US drug maker Cosette could not rely on sales performance figures to justify its termination of a $672 million merger agreement with Mayne Pharma Group.
Insurer IAG has argued Greensill investor White Oak failed to verify the existence of $140 million in receivables for fear the deal wouldn't go ahead -- conduct, it says, that was “redolent of a deal that is too good to be true”.
Construction PRO
Optus has won an appeal against a council's decision to refuse its plan to build a telecommunications tower in Killcare Heights on NSW's Central Coast.
Construction PRO
Dashing hopes for a more "compelling" offer, US private equity firm Warburg Pincus has advised land lease and retirement village operator Ingenia Communities that its $2.14 billion takeover bid is its best and final offer.
Construction PRO
BESIX Watpac has been selected as the preferred contractor to build the Macquarie Point Stadium in Hobart, a month after being selected to build a 63,000-seat stadium in Brisbane for the 2032 Olympic Games.
Construction PRO
ASX-listed alternative asset manager HMC Capital has acquired the Coburns Central shopping centre in Melbourne's west for $49 million.